(Total Views: 558)
Posted On: 02/09/2021 4:58:49 PM
Post# of 155791
Re: Boatbuilder #76960
The DSMC and/or FDA has extended the RLFTF data analysis out to 60 days. Investors drastically interpreted that as negative resulting in a 40% share price drop today. Any BigPharma influence?
Regardless, shall we be thinking that the DSMC and/or FDA is waiting for our s/c trial data to be analyzed at the 42 day point?????
That would give some comfort to what some are describing as our present situation being that for some reason, we are in a delay of data release.
Regardless, shall we be thinking that the DSMC and/or FDA is waiting for our s/c trial data to be analyzed at the 42 day point?????
That would give some comfort to what some are describing as our present situation being that for some reason, we are in a delay of data release.
(2)
(0)
